Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma

被引:67
|
作者
Berchtold, Sonja [1 ]
Gruenwald, Barbara [2 ]
Krueger, Achim [2 ]
Reithmeier, Anja [1 ]
Haehl, Teresa [1 ]
Cheng, Tao [3 ]
Feuchtinger, Annette [4 ]
Born, Diana [5 ]
Erkan, Mert [3 ,6 ]
Kleeff, Joerg [3 ]
Esposito, Irene [1 ]
机构
[1] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany
[2] Tech Univ Munich, Inst Expt Oncol & Therapy Res, D-80290 Munich, Germany
[3] Tech Univ Munich, Dept Surg, D-80290 Munich, Germany
[4] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt Pathol, Neuherberg, Germany
[5] Kantonspital Munsterlingen, Munsterlingen, Germany
[6] Koc Univ, Sch Med, Dept Surg, Istanbul, Turkey
基金
欧盟第七框架计划;
关键词
Collagen type V; beta; 1-integrin; Pancreatic ductal adenocarcinoma; Pancreatic stellate cells; Epithelial-stromal interaction; EHLERS-DANLOS-SYNDROME; STELLATE CELLS; EXTRACELLULAR-MATRIX; CANCER; EXPRESSION; STROMA; ADHESION; COL5A1; FIBRIL; IDENTIFICATION;
D O I
10.1016/j.canlet.2014.10.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Excessive matrix production by pancreatic stellate cells promotes local growth and metastasis of pancreatic ductal adenocarcinoma and provides a barrier for drug delivery. Collagen type V is a fibrillar, regulatory collagen up-regulated in the stroma of different malignant tumors. Here we show that collagen type V is expressed by pancreatic stellate cells in the stroma of pancreatic ductal adenocarcinoma and affects the malignant phenotype of various pancreatic cancer cell lines by promoting adhesion, migration and viability, also after treatment with chemotherapeutic drugs. Pharmacological and antibody-mediated inhibition of beta 1-integrin signaling abolishes collagen type V-induced effects on pancreatic cancer cells. Ablation of collagen type V secretion of pancreatic stellate cells by siRNA reduces invasion and proliferation of pancreatic cancer cells and tube formation of endothelial cells. Moreover, stable knockdown of collagen type V in pancreatic stellate cells reduces metastasis formation and angiogenesis in an orthotopic mouse model of ductal adenocarcinoma. In conclusion, paracrine loops involving cancer and stromal elements and mediated by collagen type V promote the malignant phenotype of pancreatic ductal adenocarcinoma and underline the relevance of epithelial-stromal interactions in the progression of this aggressive neoplasm. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 50 条
  • [21] Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
    Bermejo-Rodriguez, Camino
    Araos Henriquez, Joaquin
    Caligiuri, Giuseppina
    Pinto Teles, Sara
    Park, Youngkyu
    Evans, Anthony
    Barrera, Lawrence N.
    Neesse, Albrecht
    Gruetzmann, Robert
    Aust, Daniela
    Ruemmele, Petra
    Knoesel, Thomas
    Narita, Masako
    Narita, Masashi
    Campbell, Fiona
    Oehlund, Daniel
    Pilarsky, Christian
    Dow, Lukas E.
    Humbert, Patrick O.
    Biffi, Giulia
    Tuveson, David A.
    Perez-Mancera, Pedro A.
    CANCER RESEARCH, 2024, 84 (18) : 2968 - 2984
  • [22] High Level of Adropin Promotes the Progression of Pancreatic Ductal Adenocarcinoma
    Hu, Jilong
    Wu, Qinrong
    Ding, Qunhua
    Wu, Weibo
    Li, Qiyun
    Zheng, Zhinan
    CURRENT CANCER DRUG TARGETS, 2024, 24 (06) : 629 - 641
  • [23] Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
    Orianne Olivares
    Jared R. Mayers
    Victoire Gouirand
    Margaret E. Torrence
    Tristan Gicquel
    Laurence Borge
    Sophie Lac
    Julie Roques
    Marie-Noëlle Lavaut
    Patrice Berthezène
    Marion Rubis
    Veronique Secq
    Stéphane Garcia
    Vincent Moutardier
    Dominique Lombardo
    Juan Lucio Iovanna
    Richard Tomasini
    Fabienne Guillaumond
    Matthew G. Vander Heiden
    Sophie Vasseur
    Nature Communications, 8
  • [24] Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
    Olivares, Orianne
    Mayers, Jared R.
    Gouirand, Victoire
    Torrence, Margaret E.
    Gicquel, Tristan
    Borge, Laurence
    Lac, Sophie
    Roques, Julie
    Lavaut, Marie-Noelle
    Berthezene, Patrice
    Rubis, Marion
    Secq, Veronique
    Garcia, Stephane
    Moutardier, Vincent
    Lombardo, Dominique
    Iovanna, Juan Lucio
    Tomasini, Richard
    Guillaumond, Fabienne
    Vander Heiden, Matthew G.
    Vasseur, Sophie
    NATURE COMMUNICATIONS, 2017, 8
  • [25] Characterization of a novel mediator of malignant phenotype in pancreatic adenocarcinoma
    Liau, S. -S.
    Rocha, F.
    Ashley, S. W.
    Whang, E. E.
    BRITISH JOURNAL OF SURGERY, 2006, 93 (07) : 899 - 899
  • [26] LAMININ AND TYPE IV COLLAGEN IN PANCREATIC ADENOCARCINOMA
    GRIGIONI, WF
    BIAGINI, G
    CAMPIONE, O
    DERRICO, A
    MILANI, M
    VILLANACCI, V
    GARBISA, S
    VASI, V
    MARRANO, D
    MANCINI, AM
    PATHOLOGY RESEARCH AND PRACTICE, 1985, 180 (03) : 272 - 272
  • [27] Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma
    Esposito, I
    Menicagli, M
    Funel, N
    Bergmann, F
    Boggi, U
    Mosca, F
    Bevilacqua, G
    Campani, D
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (06) : 630 - 636
  • [28] Blood type as a risk factor for pancreatic ductal adenocarcinoma
    Larki, Navid Rahimi
    Skanderson, Melissa
    Tate, Janet
    Levinson, Rachel
    Hauser, Ronald G.
    Brandt, Cynthia
    Yang, Yu-Xiao
    Justice, Amy C.
    Wang, Louise
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma
    Lee, Alex Y. L.
    Dubois, Claire L.
    Sarai, Karnjit
    Zarei, Soheila
    Schaeffer, David F.
    Sander, Maike
    Kopp, Janel L.
    GUT, 2019, 68 (03) : 487 - 498
  • [30] Pancreatic ductal adenocarcinoma
    Gallmeier, E.
    Gress, T. M.
    INTERNIST, 2018, 59 (08): : 805 - 822